PHSE continues its expansion in radiopharma and enters the Belgium market with the acquisition of World Infinity Services SRL
Milan, 29 January 2025 – PHSE, a leading global group in temperature-controlled and time critical pharmaceutical logistics, announces today that it has completed the acquisition of a 70% stake in World Infinity Services SRL (WIS), a specialist Belgian logistics company focused on the international shipment of radiopharmaceuticals, the new frontier in cancer therapies.
This transaction further strengthens the PHSE Group’s focus on nuclear medicine, meeting the growing demand from pharmaceutical companies worldwide for consistent, highly specialized services capable of guaranteeing the safe international delivery of products with a very short shelf-life (even within 24/48 hours) to the patient. The acquisition also firmly establishes the Group in a new and very strategic production and distribution market, Belgium, and further expands PHSE’s overall European and Global footprint.
“We are excited to welcome World Infinity Services to our Group. WIS’s capabilities and expertise in radiopharmaceuticals, including an MIA (Manufacturer Importer Authorization) licensed facility in Liege, further enhances our GDP-compliant and IATA-certified global network for specialist healthcare distribution by air and land. Having started operations in the radiopharmaceutical market specialist segment over a decade ago, we continue to invest in our global capability in order to meet the growing needs of our customers.”, said Eddy De Vita, Executive Chairman of PHSE Group.
“We are very pleased to join a global market leader in this sector and are excited by the plans the PHSE Group has to further enhance its worldwide capabilities”, said Hans van de Maele and Andrea Demeulenaere, who will continue to run WIS, reporting to Fabio Mioli, CEO PHSE International.
As well as a global network of validated partners, the PHSE Group has 35 of its own facilities globally, employing more than 700 people and operating its own fleet of around 600 specialist vehicles. Pro-forma revenues in 2024, considering the acquisitions concluded, amounted to approximately Eu 100m.